Thus, the combination of region- and distance-based analyses demonstrate distinct but complementary information, that most CD8 T cells are localized in highly vascularized DC-rich microenvironments, and that during initiation of responses to immunotherapy, expanded effector, but not resource, CD8 T cells can infiltrate the tumor bed. The gene discussed is CD8A; the disease is neoplasm.